Sanara MedTech Inc. (SMTI) › Cash & EquivalentsSanara MedTech Inc. (SMTI) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2009-12-31: -$4.4K2010-12-31: $50.8K2011-12-31: $3.6K2012-12-31: $45.9K2013-12-31: $44.6K2014-12-31: $523.4K2015-12-31: $182.3K2016-12-31: $833.5K2017-12-31: $463.2K2018-12-31: $176.4K2019-12-31: $6.61M2020-12-31: $455.4K2021-12-31: $18.65M2022-12-31: $8.96M2023-12-31: $5.15M2024-12-31: $15.88M2025-12-31: $16.58M$16.58M2009-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$16.58M+4.4%2026-03-24Balance as of period end2024-12-31$15.88M+208.5%2026-03-24Balance as of period end2023-12-31$5.15M-42.5%2025-03-25Balance as of period end2022-12-31$8.96M-52.0%2024-03-25Balance as of period end2021-12-31$18.65M+3996.2%2023-03-20Balance as of period end2020-12-31$455.4K-93.1%2022-03-31Balance as of period end2019-12-31$6.61M+3647.8%2021-03-30Balance as of period end2018-12-31$176.4K-61.9%2021-03-30Balance as of period end2017-12-31$463.2K-44.4%2019-04-01Balance as of period end2016-12-31$833.5K+357.1%2018-03-29Balance as of period end2015-12-31$182.3K-65.2%2017-04-04Balance as of period end2014-12-31$523.4K+1074.9%2016-04-14Balance as of period end2013-12-31$44.6K-2.9%2015-05-01Balance as of period end2012-12-31$45.9K+1171.1%2014-04-30Balance as of period end2011-12-31$3.6K-92.9%2013-04-12Balance as of period end2010-12-31$50.8K—2013-04-12Balance as of period end2009-12-31-$4.4K—2012-05-01Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)